US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist
  • 2.690
  • +0.070+2.67%
Close Mar 7 16:00 ET
  • 2.690
  • 0.0000.00%
Post 20:01 ET
371.98MMarket Cap-7.47P/E (TTM)

About Compass Therapeutics Company

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Company Profile

SymbolCMPX
Company NameCompass Therapeutics
Listing DateNov 2, 2021
Issue Price3.50
Founded2014
CEODr. Thomas J. Schuetz, M.D.,PhD
MarketNASDAQ
Employees35
Fiscal Year Ends12-31
Address80 Guest Street,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02135
Phone1-617-500-8099

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Thomas J. Schuetz, M.D.,PhD
  • President, Chief Executive Officer and Vice Chairman of the Board
  • 4.87M
  • Barry Shin, J.D.,M.B.A.
  • Chief Financial Officer
  • --
  • Neil Lerner, C.P.A.
  • Vice President, Finance and Principal Accounting Officer
  • --
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Chairman of the Board
  • 222.63K
  • Ellen V. Chiniara, J.D.
  • Independent Director
  • 163.42K
  • Richard S. Lindahl
  • Independent Director
  • 147.92K
  • James P. Boylan, M.B.A.
  • Independent Director
  • 45.00K
  • Dr. Philip J. Ferneau, J.D.
  • Independent Director
  • 193.02K
  • Dr. Mary Ann Gray,PhD
  • Independent Director
  • 163.42K
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.